Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR2C | P28335 | 3/20 | 0.41 |
| ▸ | HTR2A | P28223 | 1/20 | 0.41 |
| ▸ | HTR2B | P41595 | 1/20 | 0.41 |
| ▸ | PBRM1 | Q86U86 | 1/20 | 0.35 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.34 |
| ▸ | ATM | Q13315 | 1/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.30 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL114449 | 0.67 | HTR2C (0.46) | HTR2CHTR2AHTR2BPBRM1TRPA1 | |
| SCHEMBL16956125 | 0.64 | HTR2C (0.74) | HTR2CHTR2AHTR2BTRPA1ATM | |
| SCHEMBL11245053 | 0.63 | HTR2C (0.46) | HTR2CHTR2AHTR2BPBRM1TRPA1 | |
| SCHEMBL40704 | 0.62 | — | — | |
| SCHEMBL5494561 | 0.62 | TRPA1 (0.61) | TRPA1ATMCYP1A2CYP2A6 | |
| SCHEMBL24385162 | 0.61 | HTR2C (0.41) | HTR2CHTR2AHTR2BPBRM1TRPA1 | |
| SCHEMBL29875704 | 0.61 | HTR2C (0.44) | HTR2CHTR2AHTR2BPBRM1TRPA1 | |
| SCHEMBL10779356 | 0.61 | HTR2C (0.49) | HTR2CHTR2AHTR2BPBRM1TRPA1 | |
| SCHEMBL6386133 | 0.61 | HTR2C (0.69) | HTR2CHTR2AHTR2BTRPA1ATM | |
| SCHEMBL23873432 | 0.60 | HTR2C (0.51) | HTR2CHTR2AHTR2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2004036011-A2 | BIOMOLECULAR-BASED ACTUATOR | FLORIDA STATE UNIVERSITY (US) | 2004-04-29 | — | — | WO | claimed |
| US-20130040845-A1 | METHOD FOR SCREENING RECEPTORS/LIGANDS INTERACTIONS | IMMUNE DISEASE INSTITUTE, INC. (US) | 2013-02-14 | — | — | US | disclosed |
| WO-2011103049-A2 | METHOD FOR SCREENING RECEPTORS/LIGANDS INTERACTIONS | IMMUNE DISEASE INSTITUTE, INC. (US) | 2011-08-25 | — | — | WO | disclosed |
| US-7173156-B1 | Thioacetate deprotection | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE NAVY (US) | 2007-02-06 | — | — | US | disclosed |
| US-20060003097-A1 | Fabrication of nanoparticle arrays | PURDUE RESEARCH FOUNDATION | 2006-01-05 | — | — | US | disclosed |
| WO-2005015792-A2 | FABRICATION OF NANOPARTICLE ARRAYS | PURDUE RESEARCH FOUNDATION (US) | 2005-02-17 | — | — | WO | disclosed |
| US-6673424-B1 | Devices based on molecular electronics | ARIZONA BOARD OF REGENTS | 2004-01-06 | — | — | US | disclosed |
| US-6277651-B1 | Diode laser electrochemical sensor for detecting chemical and biological analytes | CALSPAN SRL CORPORATION | 2001-08-21 | — | — | US | disclosed |